1Cell.Ai
PrivateLast Round
Series A
Nov 21, 2024
Total Funding Raised
$16.08M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
1Cell.Ai operates in Healthcare & Life Sciences and is based in Mumbai. Its latest recorded funding round was a Series A round in November 2024.
1Cell.Ai is a biotechnology company that provides an AI-powered precision oncology platform designed to accelerate the discovery of rare cell populations and improve cancer diagnostics and treatment.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Medical AI, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
1Cell.Ai Comparables
Compare 1Cell.Ai with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| One Biosciences | 84% | |
| 4baseCare | 82% | |
| Predicine | 79% |
For institutional investors. Book with your work email.
1Cell.Ai Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 21, 2024 | ||||
| Grant | Jul 11, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
1Cell.Ai Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Biotechnology Industry Research Assistance Council | Grant |
| WRVI Capital | Series A |
| Eragon Ventures | Series A |
| Singularity Growth | Series A |
| Department of Biotechnology | Grant |
| Tenacity Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 149% MoM, reaching 13.1K.
For institutional investors. Book with your work email.
1Cell.Ai Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about 1Cell.Ai's valuation, stock price, and market status.
Is 1Cell.Ai a public or private company?
1Cell.Ai is a private company.
What is the current stock price of 1Cell.Ai?
1Cell.Ai is a private company, so its shares have no public market price. Caplight tracks 1Cell.Ai's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is 1Cell.Ai worth (valuation)?
Valuation information for 1Cell.Ai is not publicly available.
Can I buy 1Cell.Ai stock?
1Cell.Ai shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was 1Cell.Ai's last funding round?
1Cell.Ai's most recent funding round was Series A on November 21, 2024.
Who are the main investors in 1Cell.Ai?
Key investors in 1Cell.Ai include Biotechnology Industry Research Assistance Council, WRVI Capital.
Will 1Cell.Ai IPO soon?
No public IPO plans have been announced for 1Cell.Ai.
How can I track 1Cell.Ai secondary market activity?
Caplight tracks bids, offers, and trades in 1Cell.Ai's shares on secondary markets.